Patient registry for newly diagnosed lung scarring using an app
Part of Lungs & breathing clinical trials.
This study sets up an international registry to follow people with newly diagnosed fibrotic interstitial lung disease (lung scarring). It uses eHealth technology (an online/app-based system) so your team can better understand your condition over time and improve future care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been newly diagnosed with fibrotic interstitial lung disease (ILD) confirmed by a lung-specialist team within the last 6 months
- You started treatment for this lung condition within the last 1 month
- You can speak, read, and write in the main language used where the study is run
- You can follow the study plan and answer questions as the study requires
- You have reliable access to the internet to use the study technology
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies whether using a home monitoring program helps people with pulmonary fibrosis track their condition. It aims to make care easier and catch changes early.
This study is testing a new way to track lung scarring (fibrosis) over time in people with conditions like IPF, other fibrotic lung diseases, or early signs of scarring. It might help doctors understand how the disease changes.
This trial is for people with scarring lung disease (pulmonary fibrosis) in Ireland. It aims to better understand and care for the condition, especially in families. The study will look at medical data and may help improve diagnosis and treatment.
This trial tests whether a digital self-management program (using a smartphone or tablet) helps people with fibrotic interstitial lung disease better manage their symptoms and quality of life. If you have this lung condition and can use a mobile device, this study could offer you extra support at home.
This study builds a community registry to learn about people affected by pulmonary fibrosis and related lung conditions, including patients, caregivers, and close family. By joining, you help researchers better understand needs and experiences in the real world.
This study uses a single lung scan to find early signs of progressive scarring (fibrosis) in people with pulmonary fibrosis. It may help doctors predict which patients will get worse faster.
Hear when a new Pulmonary Fibrosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.